Hashimoto's Thyroiditis & Autoimmune Thyroid Protocol
Hashimoto's Thyroiditis & Autoimmune Thyroid Protocol framework focused on consistent execution, practical monitoring, and safer progression.
Immunomodulatory peptide protocol targeting the autoimmune destruction of thyroid tissue in Hashimoto's, aimed at reducing TPO/TG antibody titers, restoring immune tolerance, and protecting residual thyroid function.
Who it's for
Use this as an educational framework with clinical oversight. Keep timing consistent, track response daily, and change one variable at a time after trend review. Pair protocol use with sleep, nutrition, and recovery fundamentals.
Free Peptide Guide
Hashimoto's Thyroiditis & Autoimmune Thyroid Protocol Protocol PDF
Schedule template, practical checkpoints, common mistakes, and safety guidance in one quick reference.
Free access. No spam. This form sends the shared peptide guide that is live today.
Protocol at a Glance
Cycle Duration
16 weeks on, 4 weeks off; long-term maintenance 3x/week
Target Audience
Hashimoto's patients with elevated TPO/TG antibodies and early thyroid dysfunction
| Compound | Dose | Frequency |
|---|---|---|
| Thymosin Alpha-1 Thymosin Alpha-1 — Treg restoration, TPO antibody reduction | 900 mcg SQ | 3x/week |
| BPC-157 BPC-157 — systemic anti-inflammatory, cytokine cascade reduction | 250 mcg | 2x daily |
| VIP VIP — Th1/Th17 suppression, reduces lymphocytic infiltration | 200 mcg SQ | Daily |
| KPV KPV — local NF-κB inhibition, thyroid tissue protection | 500 mcg | Daily |
Free Peptide Guide
Hashimoto's Thyroiditis & Autoimmune Thyroid Protocol Protocol PDF
Schedule template, practical checkpoints, common mistakes, and safety guidance in one quick reference.
Free access. No spam. This form sends the shared peptide guide that is live today.
Daily Schedule
Morning
Baseline review and first execution window
Log sleep, energy, and tolerance; complete planned Thymosin Alpha-1 timing if scheduled.
Midday
Adherence and symptom check
Review hydration, workload, and side effects before any changes.
Evening
Recovery closeout and next-day setup
Record outcomes, maintain schedule consistency, and prepare next-day protocol.
Safety
- Escalating side effects or new concerning symptoms require prompt clinical review.
- Avoid abrupt multi-compound changes during unstable periods.
- Maintain regular follow-up with a licensed clinician throughout the cycle.
Not appropriate for unsupervised use or as a replacement for diagnosis and medical care. Use only within a clinician-guided plan.
Who should avoid
- Anyone using this protocol without qualified medical supervision
- People with unstable medical or psychiatric conditions without specialist guidance
- Pregnant or breastfeeding individuals unless explicitly cleared by a physician
Common Mistakes
Changing multiple variables at once
Why it matters: This makes it hard to identify what improved outcomes versus what increased side effects.
How to fix: Keep one-variable changes per review cycle and log response for several days.
Ignoring adherence and recovery fundamentals
Why it matters: Protocol effectiveness drops when sleep, nutrition, and routine consistency are unstable.
How to fix: Protect daily anchors first, then optimize protocol details gradually.
FAQ
How long should Hashimoto's Thyroiditis & Autoimmune Thyroid Protocol run before reassessment?
A common window is 16 weeks on, 4 weeks off; long-term maintenance 3x/week, with periodic review of tolerance and objective trends.
Can I increase complexity quickly for faster results?
Usually no. Safer optimization comes from staged changes and clear tracking.
What should I track each day?
Track schedule adherence, symptoms, sleep quality, and any adverse effects in one log.
Key Takeaways
- Consistency with Thymosin Alpha-1 + BPC-157 execution matters more than frequent protocol changes.
- Single-variable adjustments improve safety and decision quality.
- Objective daily tracking supports better long-term outcomes.
Why This Stack Works
Hashimoto's involves Th1-dominant autoimmunity against thyroid peroxidase and thyroglobulin. Thymosin Alpha-1 restores Treg balance and suppresses autoreactive T-cells. BPC-157 reduces systemic inflammation and cytokine load. VIP suppresses Th1/Th17 polarization driving lymphocytic infiltration. KPV modulates local thyroid inflammation via NF-κB inhibition.
Clinical Research
No clinical references were provided for this stack yet.
More Immune Support Stacks
Ankylosing Spondylitis & Axial Spondyloarthropathy Protocol
An adjunctive protocol for individuals with ankylosing spondylitis and axial spondyloarthropathy, targeting the IL-17/IL-23-driven enthesitis, progressive syndesmophyte formation, and the TNF-driven inflammatory cascade that cause irreversible spinal fusion.
Ankylosing Spondylitis & Axial Spondyloarthropathy Protocol
Anti-inflammatory and joint-protective peptide protocol for ankylosing spondylitis targeting spinal inflammation, syndesmophyte prevention, and preservation of spinal mobility.
Crohn's Disease & IBD Management Protocol
Peptide-based protocol targeting intestinal inflammation, barrier repair, and mucosal immune regulation for Crohn's disease and ulcerative colitis management.
Medical disclaimer: This protocol is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any peptide protocol.
Free Peptide Guide
Hashimoto's Thyroiditis & Autoimmune Thyroid Protocol Protocol PDF
Schedule template, practical checkpoints, common mistakes, and safety guidance in one quick reference.
Free access. No spam. This form sends the shared peptide guide that is live today.